Stem cell pioneer and expert - navigating hitherto uncharted waters
Drawing on over 15 years' experience in advanced stem cell research and regenerative medicine to pioneer the production of ABCB5-positive (ABCB5+) mesenchymal stem cells and innovative treatment pathways.
Using cutting-edge, in-house process technology and quality control systems to generate state-of-the-art ABCB5+ mesenchymal stem cells ("H.F.M Stem Cells") and ATMP (Advanced Therapy Medicinal Products) in line with AMG (German Medicinal Products Act) requirements.
Translational medicine: from in-house potency assay to clinical efficacy
Science-based mechanisms-of-action translated into GMP-validated potency assays and release criteria to predict clinical efficacy.
Off-the-shelf & ready to use: serving market needs
High through-put stem cell production based on globally patented technology and expertise - catering for world-wide market needs - anytime, anyplace, anywhere.
Clinical development pipeline and established technology platform focusing on rare diseases and more
Our tried and tested patented technology platform nurturing next-generation technologies (CRISPR/Cas, iPS Technology and 3D Bioprinting), heralding the arrival of next-generation cell therapies.
ABCB5 patents – a world-wide exclusive
TICEBA - exclusive licensee of the full ABCB5 patent portfolio from Boston Children's Hospital - a teaching affiliate of Harvard Medical School, Boston, Massachusetts. Several of these were invented at the same time and are jointly owned by TICEBA.
First ABCB5 patent
First description of ABCB5+ cells and creation of TICEBA
TICEBA launches business activities
Approval granted for tissue procurement and processing
Creation of RHEACELL
Manufacturing license granted (AMG – German Medicinal Products Act) für AMESANAR®
First clinical trial using ABCB5+ cells
Technology platform patent granted ("H.F.M Stem Cells")
National marketing authorization applied for in Germany
Pediatric Investigation Plan (PIP) approved by PDCO (EMA) for RHEACELL
National marketing authorization in Germany granted for AMESANAR®
Manufacturing license granted (AMG) for EBESANAR®
State-of-the art clean room facility meeting current international standards.
A stringent quality control procedure is the hallmark of guaranteed product safety and quality in line with international GMP standards. Every product batch meets standardized, validated in-house release criteria.
Satisfying regulatory and legislative requirements and fine-tuning the Quality Assurance program to guarantee GMP-compliant processes.